Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/08/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 01/08/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
44 |
| 12/29/17 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 12/29/17 | 8-K | Current report filing |
|
3 | |
| 12/21/17 | SC TO-I/A | Issuer tender offer statement |
|
5 | |
| 12/21/17 | 8-K | Current report filing |
|
3 | |
| 12/15/17 | SC TO-I/A | Issuer tender offer statement |
|
6 | |
| 12/13/17 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | |
| 12/07/17 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 12/07/17 | 8-K | Current report filing |
|
6 |
